Evidence map›Paper›PMID 9236231›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience1997

Growth factor activity of endothelin-1 in primary astrocytes mediated by adhesion-dependent and -independent pathways.

S Cazaubon, N Chaverot, I A Romero, J A Girault, P Adamson, A D Strosberg, P O Couraud

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 99 citations in OpenAlex.

  1. Review
  2. Endothelin ETInternational journal of molecular sciences · 2021
    Review
  3. Review
  4. Article
  5. Review
  6. Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis.The international journal of biochemistry & cell biology · 2012
    Article
  7. Physiology of endothelin and the kidney.Comprehensive Physiology · 2011
    Review
  8. Review
  9. Endothelin-1 regulates oligodendrocyte development.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2009
    Article
  10. Article
  11. Endothelin-1 regulates astrocyte proliferation and reactive gliosis via a JNK/c-Jun signaling pathway.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2008
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Modulation of Kv1.5 currents by Src tyrosine phosphorylation: potential role in the differentiation of astrocytes.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2000
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

S CazaubonCentre National de la Recherche Scientifique UPR 0415, Institut Cochin de Génétique Moléculaire, 75014 Paris, France.
N Chaverot
I A Romero
J A Girault
P Adamson
A D Strosberg
P O Couraud
Institut Cochin · FRCollège de France · FRUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endothelin-1 (ET-1) has been shown to induce DNA synthesis in primary astrocytes by stimulating the extracellular signal-regulated kinase (ERK) pathway. To clarify the mechanisms responsible for the anchorage-dependent growth of astrocytes, the relationships between cell adhesion and ERK activation were investigated. Here it is reported that ET-1 promotes the formation of stress fibers and focal adhesions and the tyrosine phosphorylation of focal adhesion kinase (FAK) and paxillin, as well as Src activation and association of phosphorylated FAK with Grb2. Pretreatment of astrocytes with cytochalasin D or C3-transferase, which inhibits actin polymerization or Rho activity, respectively, prevented the activation/phosphorylation of Src, FAK, and paxillin after ET-1 stimulation; by contrast, the ERK pathway was not significantly affected. This differential activation of FAK/Src and ERK pathways was also observed with astrocytes 10 and 60 min after replating on poly-L-ornithine-precoated dishes. Collectively, these findings indicate that activation of FAK and Src is dependent on actin cytoskeleton integrity, Rho activation, and adhesion to extracellular matrix, whereas ERK activation is independent of these intracellular events and seems to correlate with activation of the newly identified protein tyrosine kinase PYK2. Induction of DNA synthesis by ET-1, however, was reduced dramatically in astrocytes pretreated with either cytochalasin D or C3-transferase. This study provides a demonstration of Rho- and adhesion-dependent activation of FAK/Src, which collaborates with adhesion-independent activation of PYK2/ERK for DNA synthesis in ET-1-stimulated astrocytes.

Indexed as

Adaptor Proteins, Signal TransducingActinsAluminum CompoundsAnimalsAstrocytesCell Adhesion MoleculesCell DivisionCells, CulturedCerebral CortexCorpus StriatumCytoskeletal ProteinsCytoskeletonDNAEndothelin-1ErbB ReceptorsFetusActinsAdaptor Proteins, Signal TransducingAluminum CompoundsCell Adhesion MoleculesCytoskeletal ProteinsDNAEndothelin-1ErbB ReceptorsFluoridesFocal Adhesion Kinase 1Focal Adhesion Protein-Tyrosine KinasesGRB2 Adaptor ProteinGrb2 protein, ratGTP-Binding ProteinsMitogen-Activated Protein KinasesNerve Tissue ProteinsPaxillinPhosphoproteinsProtein Kinase CProteinsProtein-Tyrosine KinasesPtk2 protein, ratPxn protein, ratrho GTP-Binding Proteinssrc-Family KinasestetrafluoroaluminateTyrosine

Identifiers

PMID9236231
PMCPMC6568338
OpenAlexW1962496016

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.